Pharma distribution directory 2026

    Pharmaceutical Distributors in Brazil

    Brazil’s medicine path splits three ways: national wholesalers such as Profarma, Panpharma and Santa Cruz invoicing independent drogaria, Raia Drogasil’s retail–wholesale machine feeding its own stores, and the Unified Health System buying through the Ministry of Health and state secretariats.

    Anvisa licenses manufacturers, importers and distributors and runs the serialization rules that now sit on every invoice. CMED regulates prices, which is why wholesalers compete on credit, fill rate and regional branches rather than on discounting the list. Hypera and other domestic industrials still run manufacturer-owned distribution on selected lines, so a stockist-only map under-counts who calls the drogaria. Public volume is not one tender: the Ministry of Health buys strategic and high-cost molecules, state and municipal secretariats buy the rest, and Farmácia Popular subsidises named SKUs at private counters. BioNixus fields the wholesale book, the RD DC, the Hypera fleet and the SUS desk as four accounts, because a São Paulo drogaria win does not predict a Recife hospital award.

    Updated September 2026 · Anvisa — licensed pharmaceutical manufacturers, importers and distributors; serialization and GDP inspection as of September 2026 · 14 named accounts

    Request a proposal for BrazilBrowse the 14 companies

    SUS

    Public system that still absorbs a large share of hospital and programme packs

    RD

    Raia Drogasil as retail–wholesale, not a pure chemist footnote

    3 books

    Profarma, Panpharma and Santa Cruz as the named national wholesale set

    Anvisa

    Licence plus serialization — the invoice must match the pack

    Named accounts

    Top pharmaceutical distributors in Brazil

    Public, well-known names BioNixus studies at account and SKU level. This is an editorial snapshot, not an endorsement or a market-share ranking. Cross-checked against Anvisa — licensed pharmaceutical manufacturers, importers and distributors; serialization and GDP inspection (as of 2026-09-05).
    #CompanyHQ
    01ProfarmaRio de Janeiro / São Paulo
    02PanpharmaGoiânia / national branches
    03Santa CruzSão Paulo
    04Raia Drogasil (RD)São Paulo
    05Hypera distributionSão Paulo
    06AnvisaBrasília
    07Ministério da Saúde — strategic and high-cost purchasingBrasília
    08State health secretariats (SES)State capitals
    09Farmácia PopularBrasília
    10Pague MenosFortaleza
    11DPSP / Drogaria São Paulo and PachecoSão Paulo / Rio de Janeiro
    12Municipal health secretariats (SMS)Municipal seats
    13DHL / ID Logistics Brazil life scienceSão Paulo
    14Manaus and North regional wholesalersManaus

    Primary research

    These are the distributors and wholesalers we map in Brazil

    Choosing or auditing a distribution partner in Brazil? BioNixus runs distributor due-diligence interviews, channel-share estimates and pharmacy-level availability checks. Proposal ready within 48 hours of a brief.

    Planning research in Brazil?

    Primary research, market access & HEOR. Proposals within 48 hours.

    Top market research companies in Brazil (2026)

    How the market is structured

    Independent drogaria books, RD warehouses and SUS secretariats

    A multinational affiliate or a Brazilian industrial sells to Profarma, Panpharma, Santa Cruz and a tail of regional wholesalers that still matter in the North and Northeast. Those houses deliver several times a week to independent drogarias and small chains on credit measured in days that hurt when Selic is high. Raia Drogasil, Pague Menos and other banners buy through their own DCs; RD in particular blurs wholesale and retail, which is why this directory keeps it on the distributor page instead of hiding it on a chemist list. Hypera’s distribution arm and similar manufacturer fleets still place chronic and consumer-health lines beside the appointed wholesaler. SUS purchasing is layered: Ministério da Saúde for strategic components, state secretariats for hospital formularies, municipalities for basic attention, and Farmácia Popular for subsidised retail SKUs. Cold chain for biologics and vaccines concentrates in Guarulhos, Campinas and the Rio–São Paulo axis, with 3PLs filling Amazonas and the interior where wholesale branches thin out. Write the federation unit, the outlet class and whether Farmácia Popular is in scope. A “Brazil distributor” appointment without those cuts is a coastal study.

    Local

    Profarma, Panpharma, Santa Cruz, Hypera’s fleet and North regional houses: Brazilian books that invoice drogarias and carry credit through Selic cycles.

    • Profarma
    • Panpharma
    • Santa Cruz
    • Hypera distribution

    Multinational

    International 3PLs holding GDP rooms for affiliates. They store; they do not win Farmácia Popular or an SES tender.

    • DHL / ID Logistics Brazil life science

    Regional

    LatAm trading groups that treat Brazil beside Argentina or Mexico, usually on selected imported specialty rather than SUS generics.

    Wholesalers, importers & 3PL

    Anvisa as the licence gate, Ministério da Saúde, state and municipal secretariats, Farmácia Popular, and RD / Pague Menos DCs that behave like wholesale.

    • Raia Drogasil (RD)
    • Anvisa
    • Ministério da Saúde — strategic and high-cost purchasing
    • State health secretariats (SES)
    • Farmácia Popular
    • Pague Menos
    • DPSP / Drogaria São Paulo and Pacheco
    • Municipal health secretariats (SMS)
    • Manaus and North regional wholesalers

    What is moving

    What is moving pharma distribution in Brazil

    Retail DCs taking independent volume

    RD and Pague Menos keep adding stores and warehouses. Every banner store that used to buy from Profarma is now an internal transfer, which is a share shift wholesalers feel as lost drops.

    SUS layered buying after budget resets

    Federal strategic lists, state hospital tenders and municipal basic attention do not move together. A year that looks stable in Brasília can still be a stock-out year in a Northeast SMS.

    Serialization and Anvisa inspection

    Invoice-to-pack matching raises the cost of informal secondary trade. Compliant books gain; cash markets that cannot serialize lose the innovator SKU first.

    Manufacturer fleets on consumer-health lines

    Hypera and peers still run vans. Wholesaler share on those SKUs is a residual, not the whole story, and a panel that only sees wholesale invoices will overstate the book.

    BioNixus fieldwork

    How BioNixus studies pharmaceutical distributors in Brazil

    The accounts above are the ones our field teams and analysts work with. What a brand team typically commissions from us in Brazil:
    • Independent drogaria purchase-record audits splitting Profarma, Panpharma, Santa Cruz and regional books on a chronic and consumer-health basket.
    • RD and Pague Menos DC interviews on inbound terms versus the same molecule sold into independents through national wholesalers.
    • SES and SMS tender reconstruction in two states, including payment delay and substitution, plus Farmácia Popular SKU availability at participating counters.
    • Manufacturer-fleet call checks for Hypera lines against wholesaler invoices on the same street in São Paulo and Recife.

    Healthcare market research in Brazil

    Questions

    Frequently Asked Questions

    Must a foreign laboratory appoint an exclusive Brazilian wholesaler?

    No. Affiliates typically sell to two or three national books plus regional houses, and large banners buy through their own DCs. Exclusive paper is uncommon outside selected specialty.

    How does SUS purchasing actually work?

    In layers. The Ministry of Health buys strategic and high-cost items; state secretariats buy hospital formularies; municipalities buy basic attention. Farmácia Popular subsidises named SKUs at private counters.

    Why is Raia Drogasil on a distributor directory?

    Because its DCs operate at wholesale scale and pull volume away from Profarma-type books. Treating RD only as a chemist banner hides the inbound negotiation.

    Which wholesalers still matter for independent drogarias?

    Profarma, Panpharma and Santa Cruz are the three names that recur, with regional houses still decisive in the North and parts of the Northeast.

    What does BioNixus field on Brazilian pharmaceutical distribution?

    Drogaria invoice cuts in São Paulo, Rio, Belo Horizonte, Recife and one interior city; SES and SMS tender landscaping; RD versus independent share on a named basket; and Hypera-fleet presence checks.

    Is the company order a league table?

    No. Entries are grouped as wholesale books, retail–wholesale, manufacturer fleets, Anvisa, SUS layers and 3PLs so the next call is obvious.

    Sources

    Data sources & methodology

    This directory aggregates publicly available company and channel facts — filings, brand sites, and BioNixus fieldwork in Brazil. It is an editorial snapshot of the accounts we study, not a share ranking and not a substitute for NielsenIQ, IQVIA, or another syndicated feed.

    Primary register: Anvisa — licensed pharmaceutical manufacturers, importers and distributors; serialization and GDP inspection, consulted 2026-09-05. Company classification (Local / MNC / Regional / wholesalers, importers & 3pl) reflects ownership and role in Brazil, not size.

    • Anvisa distributor licensing and serialization circulars, 2024–2026
    • Ministério da Saúde and selected SES tender notices; Farmácia Popular SKU lists, 2024–2026
    • B3 filings and presentations for Raia Drogasil, Hypera and listed wholesale groups, 2024–2025
    • BioNixus Brazil drogaria, secretariat and distributor fieldwork, 2023–2026

    BioNixus sells account-level and SKU-level primary research that complements those subscriptions. For a scoped proposal, contact the team or use the form below. Email admin@bionixus.com.

    48-hour proposal

    Need distributor and channel data in Brazil?

    Coverage, credit terms, cold-chain capability and share of pharmacy purchases by wholesaler — from the pharmacies and hospitals themselves, not a directory.

    Planning research in Brazil?

    Primary research, market access & HEOR. Proposals within 48 hours.